Search

everythinglearnresearchcommunity

for

Search:↓

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

High Nesfatin-1 and low Vitamin D may increase blood pressure and heart rate in women with PCOS.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.

Obesity is linked to skin conditions like acanthosis nigricans and skin tags, which may indicate high insulin levels.

Eating less starch and dairy helped overweight women with PCOS lose weight and improve symptoms.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

High-dose vitamin A and E with zinc improved blood sugar control and insulin function in diabetics, but may cause hair loss.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Metformin improves early signs of heart disease in women with PCOS and raises apelin levels, but doesn't significantly change artery thickness.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Women with PCOS have lower amylin levels, which are not related to their body weight.

Young women with PCOS and no other heart risk factors have normal heart function.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

AGA patients have higher heart disease risk.